Bull Of The Day: Herbalife (HLF)

Herbalife (HLF) is highlighted as a Zacks Rank #1 (Strong Buy) due to its strong value score and consistent earnings beats, averaging a positive surprise of 133% over the last year, with the most recent quarter exceeding estimates by 47.5%. Earnings estimates for 2025 and 2026 have been revised upward in the last 30 days, and the stock's valuation appears low with a forward PE of 3.5x and price to sales at 0.14x, while margins have shown improvement over the last three quarters.

Analysis

Herbalife (HLF), designated as a Zacks Rank #1 (Strong Buy) with an A for Value but a D for Growth, demonstrates a compelling turnaround narrative. The company has a strong track record of exceeding market expectations, evidenced by four consecutive earnings beats, culminating in an average positive earnings surprise of 133% over the past year. The most recent quarter saw earnings per share of $0.59, surpassing the Zacks Consensus Estimate of $0.40 by 47.5%. This consistent outperformance is further supported by upward revisions in earnings estimates; for the full year 2025, estimates have increased from $1.74 to $1.91 in the last 30 days, and for 2026, they rose from $2.26 to $2.30. Despite a noted growth contraction in the most recent quarter, HLF's valuation appears significantly undervalued with a forward P/E ratio of 3.5x and a price-to-sales ratio of 0.14x. Furthermore, margins have shown consistent improvement over the last three quarters, progressing from 3.8% to 4.0% and most recently to 4.23%, indicating enhanced operational efficiency. While past high-profile short interest once dominated headlines, current financial indicators suggest a renewed positive trajectory for the company.

Key Decisions for Investors

• Investors should consider HLF's consistent earnings outperformance and upward estimate revisions as strong indicators of improving financial health and operational execution.
• The notably low forward P/E of 3.5x and price-to-sales of 0.14x, coupled with improving margins, present a potentially attractive entry point for value-oriented investors, provided future revenue growth can be re-established.
• Monitor upcoming quarterly reports closely for signs of a reversal in the recent growth contraction and continued margin expansion to validate the positive earnings momentum and justify a long-term investment thesis.